Profile data is unavailable for this security.
About the company
Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients, and corporate clients, including routine pathology tests, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology and cytopathology, hematology, allergy and immunology, serology and microbiology, infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory.
- Revenue in AUD (TTM)674.03m
- Net income in AUD15.43m
- Incorporated2020
- Employees5.12k
- LocationAustralian Clinical Labs Ltd1868-1892 Dandenong Road, ClaytonMELBOURNE 2000AustraliaAUS
- Phone+61 30045-3688
- Websitehttps://www.clinicallabs.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eureka Group Holdings Ltd | 39.24m | 17.71m | 162.56m | 42.00 | 9.10 | 1.09 | 8.77 | 4.14 | 0.0588 | 0.0588 | 0.1302 | 0.4907 | 0.1626 | -- | 64.27 | -- | 7.34 | 6.02 | 7.54 | 6.21 | 53.43 | 50.40 | 45.13 | 33.60 | -- | -- | 0.3849 | 24.62 | 22.42 | 10.04 | 134.41 | -- | 91.86 | -- |
| Pacific Smiles Group Ltd | 173.72m | 6.61m | 294.43m | 800.00 | 42.13 | 4.89 | 7.82 | 1.69 | 0.0438 | 0.0438 | 1.09 | 0.3774 | 0.9257 | 3.88 | 57.63 | -- | 3.52 | 3.61 | 4.44 | 4.55 | 86.25 | 85.00 | 3.80 | 3.68 | 0.5689 | 2.95 | 0.5862 | 78.81 | 18.54 | 9.60 | 153.43 | -18.18 | -4.27 | -15.55 |
| Capitol Health Ltd | 229.29m | 6.14m | 314.48m | -- | 51.39 | 2.35 | 9.55 | 1.37 | 0.0057 | 0.0057 | 0.214 | 0.1256 | 0.7237 | -- | 47.34 | -- | 1.97 | 3.05 | 2.27 | 3.55 | 92.94 | 92.41 | 2.73 | 4.24 | -- | -- | 0.5219 | 130.91 | 13.81 | 11.90 | -203.87 | -- | 19.92 | 4.56 |
| Australian Unity Ltd | 2.00bn | 43.47m | 397.06m | 7.70k | -- | -- | 4.09 | 0.1987 | -- | -- | -- | -- | 0.2346 | -- | -- | 259,666.80 | 0.5105 | 0.5917 | -- | -- | -- | -- | 2.18 | 2.65 | -- | 2.25 | 0.6373 | -- | 36.50 | 12.70 | 24.19 | -- | -5.72 | -- |
| Monash IVF Group Ltd | 235.97m | 23.97m | 512.37m | 867.00 | 21.53 | 1.85 | 12.47 | 2.17 | 0.0611 | 0.0611 | 0.6014 | 0.7095 | 0.5572 | 3.88 | 13.19 | 272,169.60 | 5.67 | 5.66 | 6.74 | 6.33 | 89.52 | 89.40 | 10.17 | 11.02 | 0.2846 | 9.94 | 0.3024 | 68.46 | 11.07 | 7.23 | 18.65 | 0.4511 | 33.48 | -4.72 |
| Australian Clinical Labs Ltd | 674.03m | 15.43m | 530.82m | 5.12k | 34.30 | 3.20 | 3.76 | 0.7875 | 0.0767 | 0.0767 | 3.35 | 0.8221 | 1.14 | 6.77 | 9.12 | 131,774.80 | 2.65 | 15.43 | 3.92 | 24.15 | 82.75 | 81.10 | 2.32 | 9.32 | 0.5735 | 2.89 | 0.6646 | 44.29 | -29.99 | 12.95 | -79.86 | -- | -4.29 | -- |
| Integral Diagnostics Ltd | 456.31m | -57.85m | 575.55m | 2.00k | -- | 1.91 | -- | 1.26 | -0.2485 | -0.2485 | 1.94 | 1.29 | 0.5758 | 13.71 | 21.44 | 228,157.00 | -7.30 | 4.02 | -8.19 | 4.55 | 95.23 | 95.17 | -12.68 | 6.92 | 0.7415 | 2.04 | 0.5462 | 70.64 | 22.13 | 18.36 | 71.47 | 10.68 | 30.60 | -5.01 |
| Healius Ltd | 1.69bn | -984.10m | 1.06bn | 10.50k | -- | 1.01 | -- | 0.6288 | -1.45 | -1.43 | 2.53 | 1.45 | 0.4782 | 6.27 | 9.78 | 161,123.80 | -27.81 | 0.6198 | -33.52 | 0.7441 | 87.07 | 86.75 | -58.17 | 1.32 | 0.4713 | 1.07 | 0.606 | 195.89 | -25.43 | 0.027 | -229.96 | -- | -5.86 | -- |
| Regis Healthcare Ltd | 950.89m | -14.68m | 1.23bn | 9.00k | -- | 267.88 | 11.02 | 1.29 | -0.0488 | -0.0488 | 3.16 | 0.0152 | 0.5274 | -- | 45.73 | 105,654.40 | -0.8145 | 0.0329 | -10.71 | 0.149 | -- | -- | -1.54 | 0.0763 | 0.0716 | -- | 0.9412 | 3,882.96 | 7.16 | 7.27 | 26.67 | -- | -25.03 | -11.97 |
| Holder | Shares | % Held |
|---|---|---|
| Australian Ethical Investments Ltd. (Investment Management)as of 20 May 2024 | 18.80m | 9.31% |
| Superannuation Funds Management Corp. of South Australiaas of 22 Jul 2024 | 14.31m | 7.09% |
| Yarra Funds Management Ltd.as of 21 Aug 2023 | 10.69m | 5.30% |
| Regal Funds Management Pty Ltd.as of 18 Nov 2022 | 10.07m | 4.99% |
| Investors Mutual Ltd.as of 28 Jun 2024 | 5.55m | 2.75% |
| First Sentier Investors RQI Pty Ltd.as of 22 Jul 2024 | 5.31m | 2.63% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 4.29m | 2.12% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 2.14m | 1.06% |
| Vanguard Investments Australia Ltd.as of 30 Jun 2024 | 2.04m | 1.01% |
| DFA Australia Ltd.as of 30 Jun 2024 | 1.75m | 0.87% |
